Global Regulatory Strength & Compliance
BDR has a strong and growing presence across 45+ ROW and emerging markets, and is actively engaged in regulated markets including the United States, Europe, Brazil, Australia, and more
Compliance Standards
At BDR, compliance and quality are fundamental pillars of our global strategy. We operate in full alignment with international regulatory frameworks including FDA, EMA, ANVISA, and CDSCO. Our quality management systems meet the highest benchmarks, complying with PIC/S, Eudralex, and FDA guidelines—reflecting our unwavering commitment to global standards.
Regulatory Expertise & Expansion
Our regulatory affairs team is fully equipped to meet the evolving ICH guidelines, ensuring robust filing strategies and efficient market access across geographies. With multiple product filings currently in process, BDR continues to strengthen its pipeline to address critical therapeutic needs worldwide.
Product Registrations
Our R&D is constantly and continuously engaged in product registrations in various markets (domestic, emerging and regulated) across continents.
The core responsibility of our DRA Team is to register products in the international and domestic markets, in order to gain access for such products in shortest possible time.
Product Registrations
Our R&D is constantly and continuously engaged in product registrations in various markets (domestic, emerging and regulated) across continents.
The core responsibility of our DRA Team is to register products in the international and domestic markets, in order to gain access for such products in shortest possible time.
BDR Regulatory Certifications
Ministry of Health (MOH) Registration Status by Country
| Country/Entity | Products Under Review | MOH Approvals |
|---|
Discover Previous
IPR
Discover Next
Quality Policy
